KUALA LUMPUR, Nov 15 -- Enlitic Inc, a leading developer of artificial intelligence (AI) software has completed US$25 million in Series B-1 financing. (US$1 = RM4.15)
“Enlitic’s rapid growth, including our successful fundraising, points to the enthusiasm and confidence we have elicited in the marketplace with the development of our comprehensive AI software platform and our highly efficient business model,” said Enlitic chief executive officer, Kevin Lyman.
Thorney Investment Group, one of Australia’s leading investment groups, led the round and Enlitic’s existing investors – Capitol Health, Marubeni Corporation, Amplify Partners, The Jagen Group and Regal Funds Management – also participated.
Enlitic will use the proceeds for the next phase build-out of its comprehensive AI software platform and to further grow its global footprint with major regional partners in the healthcare industry, paving the way for market deployment next year.
In the same statement, Enlitic also announced the appointment of Lawrence Gozlan of The Jagen Group to its board of directors.
Since undergoing an executive reorganisation in June 2018, Enlitic has experienced unprecedented growth, including the completion of Series B funding with a US$15 million raise, and signing a significant joint development agreement with Marubeni Corporation and Konica-Minolta.
No comments:
Post a Comment